In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour

British Journal of Cancer

Volumn 81, Issue 2, 1999, Pages 261-268

  Hamblin, M R ^a   Rajadhyaksha, M ^a   Momma, T ^a,b   Soukos, N S ^a   Hasan, T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Pharmacokinetics; Photodynamic therapy; Photosensitizer; Polymer conjugate; Tumour vasculature

Indexed keywords

POLYLYSINE; TALAPORFIN;

ANIMAL MODEL; ARGON LASER; ARTICLE; BINDING AFFINITY; CANCER THERAPY; CONJUGATE; CONTROLLED STUDY; FLUOROSCOPY; LASER MICROSCOPE; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE TUMOR; RAT; TISSUE DISTRIBUTION; VASCULARIZATION;

EID: 0032849919     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690686     Document Type: Article

References (62)

1. Bachor R, Shea CR, Gillies R and Hasan T (1991) Photosensitized destruction of human bladder carcinoma cells treated with chlorin c6-conjugated microspheres. Proc Natl Acad Sci USA 88: 1580-1584
2. Baldwin AL and Chien S (1984) Endothelial transport of anionized and cationized ferritin in the rabbit thoracic aorta and vasa vasorum. Arteriosclerosis 4: 372-382
3. Bellnier DA, Henderson BW, Pandey RK, Potter WR and Dougherty TJ (1993) Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a. J Photochem Photobiol B 20: 55-61
4. Bernstein EF, Friauf WS, Smith PD, Cole JW, Solomon RE, Fessler JF, Thomas GF, Black C and Russo A (1991) Transcutancous determination of tissue dihematoporphyrin ether content. A device to optimize photodynamic therapy. Arch Dermatol 127: 1794-1798
5. Botliroli G, Croce AC and Vaghi P (1990) Equilibrium among hematoporphyrin derivative components. II. Effect of esterase activity. Photochem Photobiol 51: 169-174
6. Boyle RW and Dolphin D (1996) Structure and biodistribution relationships of photodynamic sensitizers. Photochem Photobiol 64: 469-485
7. Butler TP, Grantham FH and Gullino PM (1975) Bulk transfer of fluid in the interstitial compartment of mammary tumors. Cancer Res 35: 3084-3088
8. Calzavara-Pinton PG, Szeimics RM, Ortel B and Zane C (1996) Photodynamic therapy with systemic administration of photosensitizers in dermatology. J Photochem Photobiol B, 36: 225-231
9. Cuomo V, Jori G, Rihter B, Kenney ME and Rodgers MA (1990) Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies. Br J Cancer 62: 966-970
10. Davis N, Liu D, Jain AK, Jiang SY, Jiang F, Richter A and Levy JG (1993) Modified polyvinyl alcohol-benzoporphyrin derivative conjugates as phototoxic agents. Photochem Photobiol 57: 641-647
11. Duncan R and Spreafico F (1994) Polymer conjugates. Pharmacokinetic considerations for design and development. Clin Pharmacokinet 27: 290-306
12. Duska LR, Hamblin MR, Bamberg MP and Hasan T (1997) Biodistribution of charged F(ab′)2 photoimmunoconjugates in a xenograft model of ovarian cancer. Br J Cancer 75: 837-844
13. Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA and Dvorak HF (1996) The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 59: 100-115
14. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659
15. Dvorak HF, Nagy JA and Dvorak AM (1991) Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 3: 77-85
16. Dvorak HF, Nagy JA, Dvorak JT and Dvorak AM (1988) Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133: 95-109
17. Edgell CJ, Mcdonald CC and Graham JD (1983) Permanent cell line expressing human factor VIII related antigen established by hybridization. Proc Natl Acad Sci USA 80: 3734-3737
18. Frisoli JK, Tudor EG, Flotte TJ, Hasan T, Deutsch TF and Schomacker KT (1993) Pharmacokinetics of a fluorescent drug using laser-induced fluorescence. Cancer Res 53: 5954-5961
19. Fukumura D, Yuan F, Monsky WL, Chen Y and Jain RK (1997) Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 151: 679-688
20. Ghinea N and Simionescu N (1985) Anionized and cationized herne undecapeptides as probes for cell surface charge and permeability studies: differentiated labeling of endothelial plasmalemmal vesicles. J Cell Biol 100: 606-612
21. Goff BA, Bamberg M and Hasan T (1991) Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res 51: 4762-477
22. Haldenby KA, Chappell DC, Winlove CP, Parker KH and Firth JA (1994) Focal and regional variations in the composition of the glycocalyx of large vessel endothelium. J Vasc Res 31: 2-9
23. Hamblin MR and Newman EL (1994a) On the mechanism of the tumour-localising effect in photodynamic therapy. J Photochem Photobiol B 23: 3-8
24. Hamblin MR and Newman EL (1994b) Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins J Photochem Photobiol B 26: 147-157
25. Hasan T (1992) Photosensitizer delivery mediated by macromolecular carrier systems. In: Photodynamic Therapy: Basic Principles and Clinical Applications, Henderson B and Dougherty T (eds), pp. 187-200. Marcel Dekker
26. Hasan T and Parrish JA (1996) Photodynamic therapy of cancer. In: Cancer Medicine, Holland JF, Frei EI, Bast RCJ, Kufe DW, Morton DL and Weichselbaum RR (eds), pp. 739-751. Williams & Wilkins: Baltimore, MD
27. Henderson BW and Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55: 145-157
28. Henderson BW, Bellnier DA, Greco WR, Sharma A, Pandey RK, Vaughan LA, Weishaupt KR and Dougherty TJ (1997) An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res 57; 4000-4007
29. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP and Jain R (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95: 4607-4612
30. Jain RK (1987) Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6: 559-593
31. Jain RK (1988) Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658
32. Jain RK (1989) Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 81: 570-576
33. Kohn S, Nagy JA, Dvorak HF and Dvorak AM (1992) Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 67: 596-607
34. Kopecek J (1991) Targetable polymeric anticancer drugs. Temporal control of drug activity. Ann N Y Acad Sci 618: 335-344
35. Krinick NL, Sun Y, Joyner D, Spikes JD, Straight RC and Kopecek J (1994) A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light. J Biomater Sci Polym Ed 5: 303-324
36. Larson E, Howlett B and Jagendorf A (1986) Artificial reductant enhancement of the Lowry method for protein determination. Anal Biochem 155: 243-248
37. Leppala J, Kallio M, Nikula T, Nikkinen P, Liewendahl K, Jaaskelainen J, Savolainen S, Gylling H, Hiltunen J, Callaway J, Kahl S and Farkkila M (1995) Accumulation of 99mTc-low-density lipoprotein in human malignant glioma. Br J Cancer 71: 383-387
38. Ley K and Arfors KE (1986) Segmental differences of microvascular permeability for FITC-dextrans measured in the hamster cheek pouch. Microvasc Res 31: 84-99
39. Mariani G, Molea N, Bacciardi D, Boggi U, Fornaciari G, Campani D, Salvadori PA, Giulianotti PC, Mosca F, Gold DV, Sharkey RM and Goldenberg DM (1995) Initial tumor targeting, biodistribution, and pharmacokinetic evaluation of the monoclonal antibody PAM4 in patients with pancreatic cancer. Cancer Res 55: 5911s-5915s
40. Masquelier M, Vitols S and Peterson C (1986) Low-density lipoprotein as a carrier of antitumoral drugs; in vivo fate of drug-human low-density lipoprotein complexes in mice. Cancer Res 46: 3842-3847
41. Matsumura Y and Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smanes. Cancer Res 46: 6387-6392
42. Mayhan WG and Heistad DD (1985) Permeability of blood brain barrier to various sized molecules. Am J Physiol 248: H712-718
43. Nugent LJ and Jain RK (1984) Plasma pharmacokinetics and interstitial diffusion of macromolecules in a capillary bed. Am J Physiol 246: H129-137
44. Ojteg G, Nygren K and Wolgast M (1987) Permeability of renal capillaries. II. Transport of neutral and charged protein molecular probes. Acta Physiol Scand 129: 287-294
45. Orenstein A, Nelson JS, Liaw LH, Kaplan R, Kimel S and Berns MW (1990) Photochemotherapy of hypervascular dermal lesions: a possible alternative to photothermal therapy? Lasers Surg Med 10: 334-343
46. Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH and Anderson RR (1995) In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. J Invest Dermatol 104: 946-952
47. Rakestraw SL, Tompkins RG and Yarmush ML (1990) Preparation and characterization of immunoconjugates for antibody-targeted photolysis. Bioconjug Chem 1: 212-221
48. Roberts WG and Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108: 2369-2379
49. Schmidt-Erfurth U, Hasan T, Gragoudas E, Michaud N, Flotte TJ and Birngruber R (1994) Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 101: 1953-1961
50. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM and Dvorak HF (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12: 303-324
51. Seymour LW (1992) Passive tumor targeting of soluble macromolecules and drug conjugates. Crit Rev Ther Drug Carrier Syst 9: 135-187
52. Seymour LW, Duncan R, Kopeckova P and Kopecek J (1987) Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery. Cancer Treat Rev 14: 319-327
53. Simionescu M and Simionescu N (1986) Functions of the endothelial cell surface. Annu Rev Physiol 48: 279-293
54. Simionescu N, Simionescu M and Palade GE (1981) Differentiated microdomains on the luminal surface of the capillary endothelium. I. Preferential distribution of anionic sites. J Cell Biol 90: 603-613
55. Soukos NS, Hamblin MR and Hasan T (1997) The effect of charge on cellular uptake and phototoxicity of polylysine chlorin(e6) conjugates. Photochem Photobiol 65: 723-729
56. UKCCCR (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition). Br J Cancer 77: 1-10
57. van Leengoed HL, Cuomo V, Versteeg AA, van der Veen N, Jori G and Star WM (1994) In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes. Br J Cancer 69: 840-845
58. Vieweg J, Heston WD, Gilboa E and Fair WR (1994) An experimental model simulating local recurrence und pelvic lymph node metastasis following orthotopic induction of prostate cancer. Prostate 24: 291-298
59. Yeung TK, Hopewell JW, Simmonds RH, Seymour LW, Duncan R, Bellini O, Grandi M, Spreafico F, Strohalm J and Ulbrich K (1991) Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl) methacrylamide conjugates: an experimental study in the rat. Cancer Chemother Pharmacol 29: 105-111
60. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D and Jain RK (1994) Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54: 3352-3356
61. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP and Jain RK (1995) Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55: 3752-3756
62. Zunino F, Pratesi G and Pezzoni G (1987) Increased therapeutic efficacy and reduced toxicity of doxorubicin linked to pyran copolymer via the side chain of the drug. Cancer Treat Rep 71: 367-373